Exosome nanovesicles displaying G protein-coupled receptors for drug discovery

International Journal of Nanomedicine

Volumn 2, Issue 4, 2007, Pages 751-760

  Estelles, Angeles ^a   Sperinde, Jeff ^a   Roulon, Thibaut ^a   Aguilar, Barbara ^a   Bonner, Caroline ^a   LePecq, Jean Bernard ^a   Delcayre, Alain ^a,b  

^a ExoThera LLC   (United States)

^b BN ImmunoTherapeutics   (United States)

Author keywords

Antibody induction; Drug screening; Exosome; GPCR; Nanovesicles

Indexed keywords

ANTIBODY; G PROTEIN COUPLED RECEPTOR; LACTADHERIN; MEMBRANE PROTEIN; SOMATOSTATIN RECEPTOR 2;

ANIMAL CELL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CELL LINE; CELL SURFACE; CELL VACUOLE; CONTROLLED STUDY; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOSOME; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR CLONING; NONHUMAN; PROTEIN CONFORMATION; PROTEIN PURIFICATION; VALIDATION PROCESS; WESTERN BLOTTING;

CELL LINE; DRUG DESIGN; HUMANS; KIDNEY; NANOSTRUCTURES; PEPTIDE LIBRARY; PROTEIN ENGINEERING; RECEPTORS, SOMATOSTATIN; RECOMBINANT PROTEINS; TRANSPORT VESICLES;

EID: 61649124159     PISSN: 11769114     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. + T-cell apoptosis. Blood Cells Mol Dis, 35:169-73.
2. Andre F, Chaput N, Schartz NE, et al. 2004. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J Immunol, 172:2126-36.
3. Clayton A, Court J, Navabi H, et al. 2001. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J Immunol Methods, 247:163-74.
4. Delcayre A, Estelles A, Sperinde J, et al. 2005. Exosome Display technology: applications to the development of new diagnostics and therapeutics. Blood Cells Mol Dis, 35:158-68.
5. Delcayre A, Shu. H, Le Pecq JB. 2005. Dendritic cell-derived exosomes in cancer immunotherapy: exploiting nature's antigen delivery pathway. Expert Rev Anticancer Ther, 5:537-47.
6. Delcayre A, Le Pecq JB. 2006. Exosomes as novel therapeutic nanodevices. Curr Opin Mol Ther, 8:31-8.
7. Denzer K, Kleijmeer MJ, Heijnen HF, et al. 2000. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci, 113 Pt 19:3365-74.
8. Escudier B, Dorval T, Chaput N, et al. 2005. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial. J Transl Med, 3: 10.
9. Fang Y, Frutos AG, Lahiri J. 2002. G-protein-coupled receptor microarrays. Chembiochem, 3:987-91.
10. Feder J, 1980. Random sequential adsorption. J Theor Biol, 87:237-54.
11. Gether U. 2000. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev, 21:90-113.
12. Helenius A, Simons K. 1975. Solubilization of membranes by detergents. Biochim Biophys Acta, 415:29-79.
13. Hong Y, Webb BL, Pai S, et al. 2006. G-protein-coupled receptor microarrays for multiplexed compound screening. J Biomol Screen, 11:435-8.
14. Hopkins AL, Groom CR. 2002. The druggable genome. Nat Rev Drug Discov, 1:727-30.
15. Jacoby E, Bouhelal R, Gerspacher M, et al. 2006. The 7 TM G-protein-coupled receptor target family. ChemMedChem, 1:761-82.
16. Johnstone RM. 1992. The Jeanne Manery-Fisher Memorial Lecture 1991. Maturation of reticulocytes: formation of exosomes as a mechanism for shedding membrane proteins. Biochem Cell Biol, 70:179-90.
17. Kim SH, Lechman ER, Bianco N, et al. 2005. Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J Immunol, 174:6440-8.
18. Klabunde T, Hessler G. 2002. Drug design strategies for targeting G-protein-coupled receptors. Chembiochem, 3:928-44.
19. Koller KJ, Whitehorn EA, Tate E, et al. 1997. A generic method for the production of cell lines expressing high levels of 7-transmembrane receptors. Anal Biochem, 250:51-60.
20. Lamparski HG, Metha-Damani A, Yao JY, et al. 2002. Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Methods, 270:211-26.
21. Le Pecq JB. 2005. Dexosomes as a therapeutic cancer vaccine: from bench to bedside. Blood Cells Mol Dis, 35(2):129-35.
22. Lundstrom K. 2005. Structural genomics of GPCRs. Trends Biotechnol, 23:103-8.
23. Lundstrom K. 2006. Latest development in drug discovery on G protein-coupled receptors. Curr Protein Pept Sci, 7:465-70.
24. Med, Ad, News Staff. 2004. World's best-selling medicines. Med Ad News, 23:60-4.
25. Mirzabekov T, Kontos H, Farzan M, et al. 2000. Paramagnetic proteoliposomes containing a pure, native, and oriented seven-transmembrane segment protein, CCR5. Nat Biotechnol, 18:649-54.
26. Miyasaka K, Hanayama R, Tanaka M, et al. 2004. Expression of milk fat globule epidermal growth factor 8 in immature dendritic cells for engulfment of apoptotic cells. Eur J Immunol, 34:1414-22.
27. Morelli AE. 2006. The immune regulatory effect of apoptotic cells and exosomes on dendritic cells: its impact on transplantation. Am J Transplant, 6:254-61.
28. Morse MA, Garst J, Osada T, et al. 2005. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med, 3:9.
29. Oshima Y, Aoki N, Kato T, et al. 2002. Secretion of a peripheral membrane protein, MFG-E8, as a complex with membrane vesicles. Eur J Biochem, 269:1209-18.
30. Patel S, Mehta-Damani A, Shu H, et al. 2005. An analysis of variability in the manufacturing of dexosomes: implications for development of an autologous therapy. Biotechnol Bioeng, 92:238-49.
31. Peche H, Renaudin K, Beriou G, et al. 2006. Induction of tolerance by exosomes and short-term immunosuppression in a fully MHC-mismatched rat cardiac allograft model. Am J Transplant, 6:1541-50.
32. Pierce KL, Premont RT, Lefkowitz RJ. 2002. Seven-transmembrane receptors. Nat Rev Mol. Cell Biol, 3:639-50.
33. Sarramegna V, Talmont F, Demange P, et al. 2003. Heterologous expression of G-protein-coupled receptors: comparison of expression systems from the standpoint of large-scale production and purification. Cell Mol Life Sci, 60:1529-46.
34. Swift S, Lorens J, Achacoso P, et al. 1999. Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293 T-cell-based systems. Current Protocols in Immunology, Unit 10.28:Suppl 31.
35. Taylor DD, Akyol S, Gercel-Taylor C. 2006. Pregnancy-associated exosomes and their modulation of T-cell signaling. J Immunol, 176:1534-42.
36. Thery C, Regnault A, Garin J, et al. 1999. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol, 147:599-610.
37. Thery C, Zitvogel L, Amigorena S. 2002. Exosomes: composition, biogenesis and function. Nat Rev Immunol, 2:569-79.
38. Veron P, Segura E, Sugano G, et al. 2005. Accumulation of MFG-E8/ lactadherin on exosomes from immature dendritic cells. Blood Cells Mol Dis, 35:81-8.
39. Vincent-Schneider H, Stumptner-Cuvelette P, Lankar D, et al. 2002. Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T-cells. Int Immunol, 14:713-22.
40. Zitvogel L, Regnault A, Lozier A, et al. 1998. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med, 4:594-600.